Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Keros Therapeutics (KROS) Tax Rate (2020 - 2025)

Keros Therapeutics filings provide 4 years of Tax Rate readings, the most recent being 6.06% for Q4 2025.

  • On a quarterly basis, Tax Rate rose 672.0% to 6.06% in Q4 2025 year-over-year; TTM through Dec 2025 was 5.31%, a 547.0% increase, with the full-year FY2025 number at 5.31%, up 547.0% from a year prior.
  • Tax Rate hit 6.06% in Q4 2025 for Keros Therapeutics, down from 16.36% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 16.36% in Q3 2025 to a low of 40.46% in Q4 2021.
  • Median Tax Rate over the past 3 years was 3.12% (2021), compared with a mean of 0.72%.
  • Biggest five-year swings in Tax Rate: tumbled -174bps in 2021 and later soared 672bps in 2025.
  • Keros Therapeutics' Tax Rate stood at 40.46% in 2021, then skyrocketed by 98bps to 0.66% in 2024, then soared by 1024bps to 6.06% in 2025.
  • The last three reported values for Tax Rate were 6.06% (Q4 2025), 16.36% (Q3 2025), and 6.75% (Q2 2025) per Business Quant data.